What we know about brain tumor surgery in adults 75 or older
Original title: Beyond Chronological Age: A Scoping Review of Neurosurgical Intervention for Central Nervous System Tumors in the Very Elderly.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a summary of past studies, not a new treatment you can get.
The short version
This review gathered past studies on brain tumor surgery in very old adults.
What was studied. Researchers searched medical databases for studies of adults aged 75 years or older. These adults had surgery, or were being checked for surgery, for a brain or spine tumor.
What they found. Eighty reports were included, and 37 were about glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary or glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary. In glioma, taking out more of the tumor was often linked to living longer. But quality of life, thinking, caregiver strain, and time at home were rarely reported.
What this means, and what it doesn't
What it could mean: Age by itself may not decide if surgery is a good idea. The type of tumor matters a lot. You can ask your care team what surgery might mean for you.
What it doesn't mean: This does not mean surgery is right for every older adult. It is a review of studies that already happened, not a new treatment or a new trial. Most of these reports, 75 of them, looked back at old records, which makes the answers less certain. It is not a cure and it is not a promise of more time.
Source: PubMed, September 10, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.